NICOLE BRADY: Open Payments
NPI 1477280303 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 25 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $601 · 2025 $685
Food & beverage: $685
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $192 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $98 |
| Novo Nordisk Inc | 1 | $83 |
| CVRx, Inc. | 2 | $81 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| Inspire Medical Systems, Inc. | 2 | $48 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Edwards Lifesciences Corporation | 1 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
Products named: REPATHA, Kerendia, Barostim Neo System, LEQVIO, INSPIRE, VERQUVO, SAPIEN 3 Ultra RESILIA, ELIQUIS.
Industry payments across GA — which companies pay providers there.
